Deciphering 17β-estradiol-3-sulfate biotransformation: From microbial interactions to strain-level biotransformation
Wei Zhang1, Qingmiao Yu1, Hongpu Xue1
1Key Laboratory of the Three Gorges Reservoir Region's Eco-Environment, Ministry of Education, Chongqing University, Chongqing 400044, China.
None:
While biodegradation shows promise for removing 17β-estradiol-3-sulfate (E2-3S) from wastewater, its underlying mechanisms remain poorly understood. We systematically elucidated E2-3S biodegradation from both microbial community and individual strain perspectives by constructing microbial co-occurrence networks across diverse reaction environments and isolating degrading bacteria from activated sludge. The results showed that activated sludge achieved E2-3S removal greater than 90 %, though estrogenic activity reduction varied with reaction environments. Network analysis, connectivity and centrality analyses identified Pseudomonas species as the keystone taxon driving estrogenic activity reduction, supported by synergistic interactions with Azonexus, Dechloromonas and Obscuribacter species to maintain redox homeostasis and nutrient availability. We further isolated non-pathogenic Pseudomonas CE2S, which demonstrated exceptional E2-3S degradation (> 90 %) and estrogenic activity reduction (> 70 %) across concentration gradients. Two major degradation pathways were proposed for strain CE2S, including deconjugation, hydroxylation, and oxidative ring cleavage reactions, ultimately yielding low-estrogenic-activity products. To our knowledge, this work provides the first comprehensive mechanistic understanding of E2-3S biodegradation spanning community to strain levels, and reports the first isolation of an activated sludge bacterium capable of simultaneous E2-3S degradation and estrogenic activity reduction. These findings provide critical insights for understanding E2-3S biodegradation and developing bioaugmentation strategies for optimal E2-3S removal.
More Related Videos
09:49Prospecting Microbial Strains for Bioremediation and Probiotics Development for Metaorganism Research and Preservation
Published on: October 31, 2019
08:03A Tandem Liquid Chromatography–Mass Spectrometry-based Approach for Metabolite Analysis of Staphylococcus aureus
Published on: March 28, 2017
Related Concept Videos
Drug Biotransformation: Overview
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Drug Metabolism: Phase II Reactions
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
